Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.
about
Biomarkers of Alzheimer's diseaseCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseSerum albumin concentration and cognitive impairmentBody fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Zinc status and taste acuity in older Europeans: the ZENITH study.Taste acuity in response to zinc supplementation in older Europeans.Antioxidant strategies for Alzheimer's disease.Androgen receptor-mediated inhibition of cutaneous wound healing.Biomarkers of Alzheimer disease in plasmaDysregulated relationship of inflammation and oxidative stress in major depression.Admission albumin levels and functional outcome of elderly hip fracture patients: is it that important?Age-related changes to tumor necrosis factor receptors affect neuron survival in the presence of beta-amyloid.Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community.Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians.Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD miceBlood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Pharmacokinetic and pharmacodynamic alterations in older people with dementia.Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies.Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.Alterations in peripheral blood lymphocyte cytokine expression in obesity.Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease.Differences in the association between high blood pressure and cognitive functioning among the general Japanese population aged 70 and 80 years: The SONIC study.Supplemented zinc does not alter mood in healthy older European adults--a randomised placebo-controlled trial: the Zenith study.Cardiovascular risk factors and inflammatory activity among centenarians with and without dementia.Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease.Cytokines in Alzheimer's disease and vascular dementia.
P2860
Q24650667-635F5FFB-AFA1-45BC-8826-362042F11177Q27023758-DCEB3BAA-1EAD-4936-A53B-632EADDB49CFQ33917576-B7F54B02-65D9-448E-8FA1-AF789BD66B82Q34277859-45CE4589-3A5E-40CD-A7C7-A62FCD923075Q34463570-C14698F3-BDA1-4EF0-8B2B-48DC9FA7700AQ34655683-680BFA87-E4BA-4E86-89C6-FC0976EEFE3DQ34754383-2F55D1A5-4FB8-486E-A5C3-F9AB9EE58274Q34795928-CAA9D1E2-B173-4D55-932D-B21C3BBFAF6FQ36045288-632CDAC3-37D0-43CA-AD24-35B8F87B3B7DQ36892222-C70E7BF1-2011-4160-B0CE-745DAD87DD5DQ36921859-21D3FBD3-008A-4E62-AD1D-04DF5B004500Q36926352-4CC3E6B9-9A42-46C6-B0D8-07A87A7986B9Q37104395-383D97E3-17C6-43CE-86A7-F4F9D6FA1609Q37219271-833B206D-A089-4847-B83F-0A218E7DB3C4Q37273675-A68BD389-5398-4A66-A431-2BA21A4A72E2Q37413701-1DE82B25-47BE-485E-8589-EA3D9BFE6DA9Q37881948-F821ABAA-2909-46E8-888E-6F9482DBE162Q39275819-E5E4F66B-DADD-4B62-AFE6-B962DF68801EQ42019923-2C99C29A-D3A6-475A-8018-14D3EC604AEEQ46458603-EA8186FC-CEAB-4788-95CD-D0807D17DD40Q47601365-2E9E50E2-FAF7-41C1-95DC-E8E0ED708EA6Q47784892-CD8C3143-F72C-4D34-9F58-66A981F1462FQ50223168-7DDAAA95-1E23-4D4B-95F9-494FC4690F15Q50646562-42488258-806C-4705-B16D-46993025832BQ51664404-66F81D2F-44E8-4480-BAAB-9E055EDAD81CQ53353537-D089738C-2683-403E-9826-5AE49BB17503Q53396129-B085457B-DE87-4B87-B2A8-9FABFACD16E7
P2860
Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@en
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@nl
type
label
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@en
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@nl
prefLabel
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@en
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@nl
P2093
P1476
Inflammatory markers in younge ...... ents with Alzheimer's disease.
@en
P2093
Altamura C
Maurits VW
Vandenbroucke M
P304
P356
10.1016/S0022-3956(99)00016-3
P577
1999-09-01T00:00:00Z